CXCR4 and glioblastoma: A multivariate analysis incorporating these variables showed that GBM patients with high CXCR4 expression had a higher risk of poor survival compared to GBM patients with low CXCR4 expression (HR = 1.482, p < 0.001) (Figure 5B).